SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is experiencing a surge as news circulates about a significant government initiative to buy $200 billion in mortgage bonds, aiming to drive down interest rates. The community is buzzing with expectations of a major rally and potential short squeeze, anticipating increased housing transaction volume due to improved affordability. While some express caution about profit-taking, the overwhelming sentiment points to a renewed bullish outlook for the real estate sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following highly positive FDA feedback, confirming no additional clinical trials are needed for its lead HS therapy, sonelokimab, paving a clear path to regulatory submission. This significant de-risking event has ignited strong community discussion, fueling speculation of an imminent Merck buyout at a substantially higher valuation and expectations of a potential short squeeze as the market fully re-evaluates the stock's intrinsic value.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending due to its robust multi-chain presence across Solana, Base, and Cronos, leveraging LayerZero technology with a deflationary burn mechanism, alongside community excitement around its visibility on platforms like Coinbase. The vibrant community is passionately united by an ambitious vision for $CAW to become the top memecoin, aiming to flip established assets like $DOGE and drive significant volume across the crypto market.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is a prominent trending stock, driven by widespread community discussion around its potential prime contractor role in a significant drone-based border security project for Israel, which is being viewed as a major validation of its autonomous defense systems. This news, though unconfirmed by the company, has ignited strong bullish sentiment and speculation about a substantial growth "super cycle" within the broader drone and defense technology sector.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to significant U.S. and U.K. defense contracts, solidifying its position as an end-to-end national security space partner. The community is buzzing with anticipation for the Neutron rocket's debut and strong institutional interest, while some investors debate the current valuation and recent insider share transactions.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is actively discussed amidst political negotiations concerning the extension of Affordable Care Act (ACA) subsidies, with a recent House vote favoring a multi-year extension driving investor attention. The community is sharply divided; optimists foresee a potential short squeeze and significant upside if a bipartisan agreement is reached in the Senate, while others caution about declines if a favorable outcome doesn't materialize. This ongoing debate, coupled with recent analyst attention, places OSCR at the forefront of healthcare sector conversations.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending sharply downward following its announcement of a $200 million convertible notes offering, which many shareholders view as dilutive and a "fraudulent" move orchestrated to benefit short positions. This controversial financing has intensified community accusations of market manipulation and insider trading, even as underlying discussions highlight the company's strategic U.S. manufacturing expansion and ongoing speculation about a potential multi-billion dollar sale of its Recurrent Energy unit.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as natural gas prices are significantly pressured by persistent warmer-than-normal weather forecasts across the U.S. and robust production levels, creating a bearish outlook for the commodity. Community discussions highlight strong sentiment for long KOLD positions, with traders actively taking profits on its recent surges while anticipating continued weakness for natural gas, despite its reputation for extreme volatility.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst a recent analyst downgrade and a polarized debate over its long-term growth prospects within the evolving personalized healthcare and GLP-1 markets. While bulls emphasize the company's strong fundamentals, international expansion, and AI integration, a vocal bearish sentiment highlights intense competition and perceived overvaluation. The stock's high short interest and recent volatility keep investors keenly focused on its future trajectory.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is trending as investors weigh news of China's scrutiny of a recent AI acquisition against strong demand for its Ray-Ban smart glasses, which has led to a delayed international launch. The community is sharply divided, with many expressing frustration over recent stock performance and questioning the company's substantial AI investments, while others see value in its core advertising business and long-term AI potential ahead of upcoming earnings season.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Palisade Bio (NASDAQ:PALI) to "Hold"

Wall Street Zen raised shares of Palisade Bio from a "sell" rating to a "hold" rating in a research note on Saturday...

Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, Marketbeat.com...

Palisade Bio (NASDAQ:PALI) Stock Rating Upgraded by Clear Str

Clear Str raised shares of Palisade Bio to a "strong-buy" rating in a report on Monday...

Palisade Bio (NASDAQ:PALI) Upgraded at Piper Sandler

Piper Sandler upgraded shares of Palisade Bio to a "strong-buy" rating in a report on Monday...

Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Palisade Bio from a "hold" rating to a "sell" rating in a research note on Saturday...

Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know

Palisade Bio (PALI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Palisade Bio (NASDAQ:PALI) Trading Up 0.6% - Here's What Happened

Palisade Bio (NASDAQ:PALI) Stock Price Up 0.6% - Should You Buy...

FY2025 EPS Estimate for Palisade Bio Increased by Analyst

Palisade Bio, Inc. (NASDAQ:PALI - Free Report) - Analysts at Brookline Capital Management upped their FY2025 earnings per share estimates for shares of Palisade Bio in a research note issued to...

Palisade Bio (NASDAQ:PALI) Announces Earnings Results, Misses Estimates By $0.06 EPS

Palisade Bio (NASDAQ:PALI - Get Free Report) issued its earnings results on Monday. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.32) by...

Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Palisade Bio (PALI), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

This account has been verified as an official PALI representative.

Verified Account

Palisade Bio

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.

Palisade Bio Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

PALI
Palisade Bio Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest PALI News

PALIPalisade Bio Inc